Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Horga

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Revista De Neurologia|February 1, 2000
[Bioequivalence and generic drugs. I. Studies of bioequivalence, considering the theoretical basis, design and use]P Zapater, J F Horga
Revista De Neurologia|March 24, 2000
[Bio-equivalence and generic drugs. Studies of bio-equivalence. II. Special situations. Reflections on problems which may arise with drugs habitually used in neurology]P Zapater, J F Horga
Revista De Neurologia|May 7, 1999
[Entacapone++ : a new catechol-O-methyltransferase inhibitor which improves the response to levodopa in patients with Parkinson disease and fluctuating motor function]J F Horga de la Parte
Revista De Neurologia|July 21, 2007
[Combination therapy in epilepsy: the need, the absence of evidence and the rational approach]J F Horga de la Parte
Brain Research|December 24, 1997
Neuroprotection by the novel calcium antagonist PCA50938, nimodipine and flunarizine, in gerbil global brain ischemiaP Zapater, J Moreno, J F Horga
Revista De Neurologia|September 19, 2007
[Natalizumab in the treatment of multiple sclerosis]A Horga, J F Horga de la Parte
Revista De Neurologia|March 8, 2006
[Pregabalin: new therapeutic contributions of calcium channel alpha2delta protein ligands on epilepsy and neuropathic pain]J F Horga de la Parte, A Horga
Medicina Clinica|February 18, 1995
[Hypoprothrombinemia associated with cefonicid]H Monerris, J F Horga, M Pérez-Mateo
Expert Review of Clinical Pharmacology|December 24, 2015
Variations of pharmacokinetics of drugs in patients with cirrhosisM A Pena, J F Horga, P Zapater
Revista De Neurologia|February 2, 2006
[Oxcarbazepine in the treatment of epilepsy. A review and update]J F Horga de la Parte, A Horga
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Revista De Neurologia|February 1, 2000
[Bioequivalence and generic drugs. I. Studies of bioequivalence, considering the theoretical basis, design and use]P Zapater, J F Horga
Revista De Neurologia|March 24, 2000
[Bio-equivalence and generic drugs. Studies of bio-equivalence. II. Special situations. Reflections on problems which may arise with drugs habitually used in neurology]P Zapater, J F Horga
Revista De Neurologia|May 7, 1999
[Entacapone++ : a new catechol-O-methyltransferase inhibitor which improves the response to levodopa in patients with Parkinson disease and fluctuating motor function]J F Horga de la Parte
Revista De Neurologia|July 21, 2007
[Combination therapy in epilepsy: the need, the absence of evidence and the rational approach]J F Horga de la Parte
Brain Research|December 24, 1997
Neuroprotection by the novel calcium antagonist PCA50938, nimodipine and flunarizine, in gerbil global brain ischemiaP Zapater, J Moreno, J F Horga
Revista De Neurologia|September 19, 2007
[Natalizumab in the treatment of multiple sclerosis]A Horga, J F Horga de la Parte
Revista De Neurologia|March 8, 2006
[Pregabalin: new therapeutic contributions of calcium channel alpha2delta protein ligands on epilepsy and neuropathic pain]J F Horga de la Parte, A Horga
Medicina Clinica|February 18, 1995
[Hypoprothrombinemia associated with cefonicid]H Monerris, J F Horga, M Pérez-Mateo
Expert Review of Clinical Pharmacology|December 24, 2015
Variations of pharmacokinetics of drugs in patients with cirrhosisM A Pena, J F Horga, P Zapater
Revista De Neurologia|February 2, 2006
[Oxcarbazepine in the treatment of epilepsy. A review and update]J F Horga de la Parte, A Horga
Pageof 4